Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
GlobeNewswire
· EVX-01 induced positive clinically relevant immune responses in all assessed patients
· Booster immunizations tended to..